“A missed opportunity”: Wemos’ reaction to VIG’s code of conduct 2020
The Dutch branches of innovative pharmaceutical companies – has failed to set out a moral compass that answers urgent societal questions regarding high medicine prices and the pharmaceutical industry. Read more